Latest News

Greifswald is getting a new research building for community medicine, where researchers want to find out more about dementia, cardiovascular diseases, and cancer connected with demographic change. The DZHK site in Greifswald will also move into the future new building.

Dr. Wesley Abplanalp is an American physiologist and basic scientist working on cardiovascular inflammation and regeneration. He is part of the research group of DZHK board member Prof. Stefanie Dimmeler at the Institute of Cardiovascular Regeneration at the Goethe-University...

How can older patients suffering from multiple chronic diseases be better cared for? A clinical trial is testing a new treatment approach in patients with chronic heart failure, psychological distress, and at least two other concomitant physical illnesses. Especially when mental...

The inner surface of blood vessels is lined by a wafer-thin layer of cells known as the endothelium, which forms a crucial barrier between blood and the surrounding tissue. The single-layered cell structure promotes the exchange of oxygen and nutrients, while simultaneously...

Revacept is a novel platelet inhibitor that binds specifically to injured blood vessels and can be used safely during catheter interventions. This is now demonstrated in a study enrolling patients with narrowed coronary arteries co-funded by the German Centre for Cardiovascular...